Results 131 to 140 of about 2,263 (160)

Drospirenone (Slynd)

Canadian Journal of Health Technologies
CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire   +1 more source

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

Journal of Clinical Endocrinology and Metabolism, 2022
Laure Morimont, Ulysse Gaspard, Jonathan Douxfils   +2 more
exaly  

Drospirenone

Reactions Weekly, 2016
openaire   +1 more source

Drospirenone/ethinylestradiol

Reactions Weekly, 2022
openaire   +1 more source

Ethinylestradiol/drospirenone

Reactions Weekly, 2007
openaire   +1 more source

Ethinylestradiol/drospirenone

Reactions Weekly, 2011
openaire   +1 more source

Drospirenone and its antialdosterone properties

Climacteric, 2007
Paolo Mannella, Tommaso Simoncini
exaly  

Sex steroids and metabolic responses in mussels Mytilus galloprovincialis exposed to drospirenone

Ecotoxicology and Environmental Safety, 2017
Tiziana Cappello, Denise Fernandes, Maria Maisano   +2 more
exaly  

Ethinylestradiol/drospirenone

Reactions Weekly, 2014
openaire   +2 more sources

Estradiol + drospirenone.

Prescrire international, 2007
Menopause: yet another poorly assessed combined oestrogen and progestin product. This estradiol-drospirenone combination is just one more hormone replacement treatment for menopausal symptoms. When choosing postmenopausal hormone treatments, it is better to use a combination that includes a better-assessed progestin such as norethisterone.
openaire   +1 more source